| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Johnson & Johnson's strong focus on product development highlights its commitment to advancing healthcare solutions. The ongoing development and approval of new therapies reflect a proactive approach to meet the evolving needs of patients and healthcare providers. This dedication to innovation positions the company well in a competitive market. However, navigating regulatory challenges can pose risks to timely product launches. |
| The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.2 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for JNJ since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0, and the negative at -0.2 on 2025-11-06. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (0.1) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| JNJ | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-06 | 0%(0%) | 0 | 0% | -0.2 | 0.1 | -1 | |||||||
| 2025-11-05 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| 2025-11-04 | 0%(0%) | 0 | 0% | -0.3 | -0.9 | -1 | |||||||
| 2025-11-03 | 0%(0%) | 0 | 0% | -0.6 | -2.7 | -1 | |||||||
| 2025-11-02 | 0%(0%) | 0 | 0% | -0.3 | -0.7 | -1 | |||||||
| 2025-11-01 | 0%(0%) | 0 | 0% | -0.3 | -0.7 | -1 | |||||||
| 2025-10-31 | 0%(0%) | 0 | 0% | -0.1 | 0.5 | -1 | |||||||
| 2025-10-30 | 0%(0%) | 0 | 0% | 0.1 | 1.6 | -1 | |||||||
| 2025-10-29 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2025-10-28 | 0%(0%) | 0 | 0% | 0.1 | 1.5 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-06 17:03:21 Participation in industry conferences reflects Johnson & Johnson's strategic engagement with healthcare trends and investor relations. |
| 2025-11-06 17:03:21 Analysts are actively monitoring Johnson & Johnson for potential investment opportunities, suggesting positive expectations for the company. |
| 2025-11-06 17:03:21 Johnson & Johnson's ongoing development and approval of new therapies indicate a strong commitment to innovation in healthcare solutions. |
| 2025-11-06 17:03:21 Johnson & Johnson's stock shows a slight gain, which suggests a favorable outlook among investors and stability in its financial performance. |
| 2025-11-06 17:03:21 The approval of Johnson & Johnson's drug Caplyta as an add-on treatment for major depressive disorder signifies a positive impact on the company's product offerings and market potential. |